Cited by 102Sirtuins and Resveratrol in MedicineCholesterol and Lipid MetabolismLipid metabolism and disorders

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men

Dash, Satya, Xiao, Changting, Morgantini, Cecilia, Szeto, Linda, Lewis, Gary F.·2013·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/atvbaha.113.302342

Open this paper in CoChat — free account

Abstract

Objective—: Overproduction of hepatic apolipoprotein B (apoB)-100 containing very low-density lipoprotein particles and intestinal apoB-48 containing chylomicrons contributes to hypertriglyceridemia seen in conditions such as obesity and insulin resistance. Some, but not all, preclinical and clinical studies have demonstrated that the polyphenol resveratrol ameliorates insulin resistance and hypertriglyceridemia. Here, we assessed intestinal and hepatic lipoprotein turnover, in humans, after 2 weeks of treatment with resveratrol (1000 mg daily for week 1 followed by 2000 mg daily for week 2) or placebo. Approach and Results—: Eight overweight or obese individuals with mild hypertriglyceridemia were studied on 2 occasions, 4 to 6 weeks apart, after treatment with resveratrol or placebo in a randomized, double-blinded, crossover study. Steady-state lipoprotein kinetics was assessed in a constant fed state with a primed, constant infusion of deuterated leucine. Resveratrol treatment did not significantly affect insulin sensitivity (homeostasis model of assessment of insulin resistance), fasting or fed plasma triglyceride concentration. Resveratrol reduced apoB-48 production rate by 22% ( P =0.007) with no significant effect on fractional catabolic rate. Resveratrol reduced apoB-100 production rate by 27% ( P =0.02) and fractional catabolic rate by 26% ( P =0.04). Conclusions—: These results indicate that 2 weeks of high-dose resveratrol reduces intestinal and hepatic lipoprotein particle production. Long-term studies are needed to evaluate the potential clinical benefits of resveratrol in patients with hypertriglyceridemia, who have increased concentrations of triglyceride-rich lipoprotein apoB-100 and apoB-48. Clinical Trial Registration—: URL: www.clinicaltrials.gov . Unique identifier: NCT01451918.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/atvbaha.113.302342

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, É., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,840
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,370
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
Effect of 6-Month Calorie Restriction on Biomarkers of Longevity, Metabolic Adaptation, and Oxidative Stress in Overweight Individuals: A Randomized Controlled Trial
Heilbronn, L. K., de Jonge, L., Frisard, M. I., DeLany, J. P., Larson-Meyer, D. E., Rood, J., Nguyen, T., Martin, C. K., Volaufova, J., Most, M. M., et al. (2006) · JAMA · doi:10.1001/jama.295.13.1539 · Cited by 969
Long-Term Calorie Restriction Is Highly Effective in Reducing the Risk for Atherosclerosis in Humans
Fontana, L., Meyer, T. E., Klein, S., & Holloszy, J. O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308291101 · Cited by 902

Flagged first, then by citations

Show all 33 references

Research works printed but not linked: 1

Veilleux A, Grenier E, Carpentier A, Richard D, Levy E. Alterations in intestinal insulin signaling in obese subjects and their effect on lipid and lipoprotein metabolism (abstract). Diabetes. 2012;61:A15.

Sorted by citations

Targeting adipose tissue in the treatment of obesity-associated diabetes
Kusminski, C. M., Bickel, P. E., & Scherer, P. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.75 · Cited by 678
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 583
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523
Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms
Xu, L., Li, Y., Dai, Y., & Peng, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.015 · Cited by 463
Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review
Amiot, M. J., Riva, C., & Vinet, A. (2016) · Obesity Reviews · doi:10.1111/obr.12409 · Cited by 465
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440
Resveratrol and diabetes: from animal to human studies
Szkudelski, T., & Szkudelska, K. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.013 · Cited by 364
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
Zordoky, B. N. M., Robertson, I. M., & Dyck, J. R. B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.016 · Cited by 346
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials
Liu, K., Zhou, R., Wang, B., & Mi, M. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.082024 · Cited by 331
The pharmacology of resveratrol in animals and humans
Park, E.-J., & Pezzuto, J. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.014 · Cited by 302
Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis
Potì, F., Santi, D., Spaggiari, G., Zimetti, F., & Zanotti, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020351 · Cited by 256
Health Effects of Resveratrol: Results from Human Intervention Trials
Ramírez-Garza, S. L., Santos, E. P. L., Marhuenda‐Muñoz, M., Storniolo, C. E., Tresserra‐Rimbau, A., Vallverdú‐Queralt, A., & Lamuela-Raventós, R. M. (2018) · Nutrients · doi:10.3390/nu10121892 · Cited by 254
Resveratrol, Metabolic Syndrome, and Gut Microbiota
Chaplin, A. M. L., Carpéné, C., & Mercader, J. (2018) · Nutrients · doi:10.3390/nu10111651 · Cited by 256
Resveratrol supplementation: Where are we now and where should we go?
Novelle, M. G., Wahl, D., Diéguez, C., Bernier, M., & de Cabo, R. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.002 · Cited by 253
The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases
Li, S., Tan, H., Wang, N., Cheung, F., Hong, M., & Feng, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8394818 · Cited by 199
New insights into the regulation of chylomicron production
Dash, S., Xiao, C., Morgantini, C., & Lewis, G. F. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034338 · Cited by 194
Self-citation
Novel Role of the SIRT1 in Endocrine and Metabolic Diseases
Lu, C., Zhao, H., Liu, Y., Yang, Z., Yao, H., Liu, T., Gou, T., Wang, L., Zhang, J., Tian, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.78654 · Cited by 160
Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism
Zanotti, I., Dall’Asta, M., Mena, P. R., Mele, L., Bruni, R., Ray, S., & Rio, D. D. (2014) · Food & Function · doi:10.1039/c4fo00670d · Cited by 160
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
Bo, S., Ponzo, V., Ciccone, G., Evangelista, A., Saba, F., Goitre, I., Procopio, M., Pagano, G. F., Cassader, M., & Gambino, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.010 · Cited by 146
An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol
Malhotra, A., Bath, S., & Elbarbry, F. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/803971 · Cited by 143
Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial
Timmers, S., de Ligt, M., Phielix, E., van de Weijer, T., Hansen, J., Moonen‐Kornips, E., Schaart, G., Kunz, I., Hesselink, M. K. C., Schrauwen‐Hinderling, V. B., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0499 · Cited by 139
Resveratrol and obesity: can resveratrol relieve metabolic disturbances?
de Ligt, M., Timmers, S., & Schrauwen, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.11.012 · Cited by 135
The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials
Izzo, C., Annunziata, M., Melara, G., Sciorio, R., Dallio, M., Masarone, M., Federico, A., & Persico, M. (2021) · Nutrients · doi:10.3390/nu13030933 · Cited by 138
Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial
van der Made, S. M., Plat, J., & Mensink, R. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118393 · Cited by 131
Resveratrol, human health and winemaking perspectives
Pastor, R. F., Restani, P., Di Lorenzo, C., Orgiu, F., Teissedre, P.-L., Stockley, C., Ruf, J. C., Quini, C. I., Garcìa Tejedor, N., Gargantini, R., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1400517 · Cited by 123
Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art
Pagliaro, B., Santolamazza, C., Simonelli, F., & Rubattu, S. D. (2015) · BioMed Research International · doi:10.1155/2015/918069 · Cited by 120
Significance of Resveratrol in Clinical Management of Chronic Diseases
Wahab, A., Gao, K., Jia, C., Zhang, F., Tian, G., Murtaza, G., & Chen, J. (2017) · Molecules · doi:10.3390/molecules22081329 · Cited by 111
Human Sirtuin Regulators: The “Success” Stories
Curry, A. M., White, D. S., Donu, D., & Cen, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.752117 · Cited by 107
Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility
Oyenihi, O. R., Oyenihi, A. B., Adeyanju, A. A., & Oguntibeju, O. O. (2016) · Journal of Diabetes Research · doi:10.1155/2016/9737483 · Cited by 109
Efficacy of Polyphenols in the Management of Dyslipidemia: A Focus on Clinical Studies
Feldman, F., Koudoufio, M., Desjardins, Y., Spahis, S., DELVIN, E. E., & Levy, E. H. (2021) · Nutrients · doi:10.3390/nu13020672 · Cited by 82
Adipose tissue NAD + biology in obesity and insulin resistance: From mechanism to therapy
Yamaguchi, S., & Yoshino, J. (2017) · BioEssays · doi:10.1002/bies.201600227 · Cited by 86
Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes
de Ligt, M., Bruls, Y. M. H., Hansen, J., Habets, M.-F., Havekes, B., Nascimento, E. B. M., Moonen-Kornips, E., Schaart, G., Schrauwen-Hinderling, V. B., van Marken Lichtenbelt, W., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.04.004 · Cited by 79
Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance
Revelo, X. S., Ghazarian, M., Chng, M. H. Y., Luck, H., Kim, J. H., Zeng, K., Shi, S. Y., Tsai, S. J., Lei, H., Kenkel, J. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.024 · Cited by 83
Self-citation
Effects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention
Guthrie, A. R., Chow, H. ‐. S., & Martinez, J. A. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.294 · Cited by 78
Recent advances in triacylglycerol mobilization by the gut
Xiao, C., Stahel, P., Carreiro, A. L., Buhman, K. K., & Lewis, G. F. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.12.001 · Cited by 77
Self-citation
Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease
Liu, C., Liao, J., & Li, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i11.1964 · Cited by 75
Dual PPARα/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction
Kalliora, C., Kyriazis, I. D., Oka, S., Lieu, M., Yue, Y., Área-Gómez, E., Pol, C. J., Tian, Y., Mizushima, W., Chin, A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129556 · Cited by 77
The Role of Resveratrol Administration in Human Obesity
Mongioì, L. M., La Vignera, S., Cannarella, R., Cimino, L., Compagnone, M., Condorelli, R. A., & Calogero, A. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094362 · Cited by 71
Are epigenetic drugs for diabetes and obesity at our door step?
Arguelles, A. O., Meruvu, S., Bowman, J. D., & Choudhury, M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.12.001 · Cited by 70
Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment
Korsholm, A. S., Kjær, T. N., Ørnstrup, M. J., & Pedersen, S. B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030554 · Cited by 71
Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor
Xue, Z., Li, D., Yu, W., Zhang, Q., Hou, X., He, Y., & Kou, X. (2017) · Food & Function · doi:10.1039/c6fo01810f · Cited by 78
The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials
Huang, H., Chen, G., Liao, D., Zhu, Y., Pu, R., & Xue, X. (2016) · Obesity Reviews · doi:10.1111/obr.12458 · Cited by 73
Novel therapeutics for type 2 diabetes: insulin resistance
Altaf, Q. A., Barnett, A. H., & Tahrani, A. A. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12400 · Cited by 66
Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action
Oshaghi, E. A., Goodarzi, M. T., Higgins, V., & Adeli, K. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1343274 · Cited by 62
Resveratrol and Related Stilbenoids, Nutraceutical/Dietary Complements with Health‐Promoting Actions: Industrial Production, Safety, and the Search for Mode of Action
Navarro, G., Martínez‐Pinilla, E., Ortiz, R., Noé, V., Ciudad, C. J., & Franco, R. (2018) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12359 · Cited by 64
No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial
de Ligt, M., Bergman, M., Mancilla, R., Essers, J. M. N. H., Moonen‐Kornips, E., Havekes, B., Schrauwen‐Hinderling, V. B., & Schrauwen, P. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa125 · Cited by 61
New and emerging regulators of intestinal lipoprotein secretion
Xiao, C., Dash, S., Morgantini, C., & Lewis, G. F. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.047 · Cited by 60
Self-citation
Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1
Pang, J., Raka, F., Heirali, A., Shao, W., Liu, D., Gu, J., Feng, J. N., Mineo, C., Shaul, P. W., Qian, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38259-1 · Cited by 58
Remnant cholesterol and ischemic heart disease
Varbo, A., & Nordestgaard, B. G. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000093 · Cited by 56
Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics
Björnson, E., Packard, C. J., Adiels, M., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Sihlbom, C., Thorsell, A., Zhou, H., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12877 · Cited by 54
Challenges in Analyzing the Biological Effects of Resveratrol
Erdogan, C. S., & Vang, O. (2016) · Nutrients · doi:10.3390/nu8060353 · Cited by 55
The Potential to Fight Obesity with Adipogenesis Modulating Compounds
Zhao, J., Zhou, A., & Qi, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042299 · Cited by 55
Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
Xu, J., Shen, J., Yuan, R., Jia, B., Zhang, Y., Wang, S., Zhang, Y., Liu, M., & Wang, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.796207 · Cited by 53
Resveratrol Action on Lipid Metabolism in Cancer
Kisková, T., & Kassayová, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112704 · Cited by 52
Resveratrol preserves the function of human platelets stored for transfusion
Lannan, K. L., Refaai, M. A., Ture, S. K., Morrell, C. N., Blumberg, N., Phipps, R. P., & Spinelli, S. L. (2015) · British Journal of Haematology · doi:10.1111/bjh.13862 · Cited by 50
Resveratrol downregulates PCSK9 expression and attenuates steatosis through estrogen receptor α-mediated pathway in L02 cells
Jing, Y., Hu, T., Lin, C., Xiong, Q., Liu, F., Yuan, J. J., Zhao, X., & Wang, R. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.05.019 · Cited by 52
The effects of resveratrol supplementation in overweight and obese humans: a systematic review of randomized trials
Christenson, J., Whitby, S. J., Mellor, D., Thomas, J., McKune, A., Roach, P. D., & Naumovski, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0035 · Cited by 47
Dietary Polyphenols against Metabolic Disorders: How Far Have We Progressed in the Understanding of the Molecular Mechanisms of Action of These Compounds?
García‐Conesa, M. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.980499 · Cited by 50
Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging
Uddin, M. J., Farjana, M., Moni, A., Hossain, K. S., Hannan, M. A., & Ha, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158258 · Cited by 48
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects
Pereira, T. D. M. C., Pimenta, F. S., Porto, M. L., Baldo, M. P., Campagnaro, B. P., Gava, A. L., Meyrelles, S. S., & Vasquez, E. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081273 · Cited by 43
No effect of resveratrol on VLDL‐TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease
Poulsen, M. K., Nellemann, B., Bibby, B. M., Stødkilde‐Jørgensen, H., Pedersen, S. B., Grønbæk, H., & Nielsen, S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13409 · Cited by 41
Hypoglycemic Effect of Resveratrol: A Systematic Review and Meta-Analysis
García-Martínez, B. I., Ruíz-Ramos, M., Pedraza‐Chaverrí, J., Santiago‐Osorio, E., & Mendoza-Núñez, V. M. (2021) · Antioxidants · doi:10.3390/antiox10010069 · Cited by 38
A Review on Rhubarb-Derived Substances as Modulators of Cardiovascular Risk Factors—A Special Emphasis on Anti-Obesity Action
Liudvytska, O., & Kołodziejczyk-Czepas, J. (2022) · Nutrients · doi:10.3390/nu14102053 · Cited by 40
Effect of Polyphenol-Rich Interventions on Gut Microbiota and Inflammatory or Oxidative Stress Markers in Adults Who Are Overweight or Obese: A Systematic Review and Meta-Analysis
González-Gómez, Á., Cantone, M., García‐Muñoz, A. M., Victoria‐Montesinos, D., Lucas-Abellán, C., Serrano‐Martínez, A., Muñoz-Morillas, A. M., & Morillas-Ruiz, J. M. (2025) · Nutrients · doi:10.3390/nu17152468 · Cited by 37
Critical review of resveratrol in xenobiotic-induced hepatotoxicity
McGill, M. R., Du, K., Weemhoff, J. L., & Jaeschke, H. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.11.003 · Cited by 37
Resveratrol as a Protective Molecule for Neuroinflammation: A Review of Mechanisms
Renaud, J., & Martinoli, M. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140617101332 · Cited by 37
The role of resveratrol in diabetes and obesity associated with insulin resistance
Hoca, M., Becer, E., & Vatansever, H. S. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1893338 · Cited by 38
Experimental Studies of the Molecular Pathways Regulated by Exercise and Resveratrol in Heart, Skeletal Muscle and the Vasculature
Dolinsky, V. W., & Dyck, J. R. B. (2014) · Molecules · doi:10.3390/molecules190914919 · Cited by 36
Influence of high fat diet and resveratrol supplementation on placental fatty acid uptake in the Japanese macaque
O’Tierney-Ginn, P., Roberts, V. H. J., Gillingham, M. B., Walker, J., Glazebrook, P. A., Thornburg, K. L. R., Grove, K. L., & Frias, A. E. (2015) · Placenta · doi:10.1016/j.placenta.2015.06.002 · Cited by 33
Resveratrol: Latest Scientific Evidences of its Chemical, Biological Activities and Therapeutic Potentials
Saad, N. M., Sekar, M., Gan, S. H., Lum, P. T., Vaijanathappa, J., & Ravi, S. (2020) · Pharmacognosy Journal · doi:10.5530/pj.2020.12.240 · Cited by 30
Grape seed and skin extract reduces pancreas lipotoxicity, oxidative stress and inflammation in high fat diet fed rats
Aloui, F., Charradi, K., Hichami, A., Selvakumar, S., Khan, N. A., Limam, F., & Aouani, E. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.017 · Cited by 30
Postprandial glycemic and lipidemic effects of black rice anthocyanin extract fortification in foods of varying macronutrient compositions and matrices
Ou, S. J. L., Yang, D., Pranata, H. P., Tai, E. S., & Liu, M. H. (2023) · npj Science of Food · doi:10.1038/s41538-023-00233-y · Cited by 28
Usefulness of resveratrol supplementation in decreasing cardiometabolic risk factors comparing subjects with metabolic syndrome and healthy subjects with or without obesity: meta-analysis using multinational, randomised, controlled trials
Sergi, C. M., Chiu, B., Feulefack, J., Shen, F., & Chiu, B. (2020) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2020.95884 · Cited by 23
Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review
Bagherniya, M., Johnston, T. P., & Sahebkar, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200427092114 · Cited by 22
Resveratrol inhibits dysfunction of dendritic cells from chronic obstructive pulmonary disease patients through promoting miR-34.
Wang, X., Zhang, C., Huang, G., Han, D., Guo, Y. C., Meng, X., & Kan, C. (2015) · PubMed Central · Cited by 19
The Clock‐NAD+‐Sirtuin connection in nonalcoholic fatty liver disease
Aggarwal, S., Trehanpati, N., Nagarajan, P., & Ramakrishna, G. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30772 · Cited by 17
The Growing Problem of Obesity
Schmidt, A. M. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305753 · Cited by 17
Supplementation of grape seed and skin extract to orlistat therapy prevents high-fat diet-induced murine spleen lipotoxicity
Bedhiafi, T., Charradi, K., Azaiz, M. B., Mahmoudi, M., Msakni, I., Jebari, K., Bouziani, A., Limam, F., & Aouani, E. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0743 · Cited by 17
The effects of phytochemicals on serum triglycerides in subjects with hypertriglyceridemia: A systematic review of randomized controlled trials
Tehrani, S. D., Shojaei, M., Bagherniya, M., Pirro, M., & Sahebkar, A. (2023) · Phytotherapy Research · doi:10.1002/ptr.7763 · Cited by 14
The Journey of Resveratrol from Vineyards to Clinics
Venkat, R., Verma, E., Daimary, U. D., Kumar, A., Girisa, S., Dutta, U., Ahn, K. S., & Kunnumakkara, A. B. (2022) · Cancer Investigation · doi:10.1080/07357907.2022.2115057 · Cited by 12
Aterofisiol® in carotid plaque evolution
Serra, R., Amato, B., Compagna, R., Amato, M., Gallelli, L., & de Franciscis, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s87609 · Cited by 10
Effects of resveratrol on mitochondrial biogenesis and physiological diseases
Uriho, A., Xue Ming, T. A. N. G., Le, G., Yang, S., Harimana, Y., Papy, I. S., Yiping, L., Zhang, K., Ma, S., & Muhoza, B. (2020) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-020-00492-0 · Cited by 10
The Gut Microbiome Affects Atherosclerosis by Regulating Reverse Cholesterol Transport
Jiang, Y., Pang, S., Liu, X., Wang, L., & Liu, Y. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10480-3 · Cited by 8
Xenohormesis: Applying Evolutionary Principles to Contemporary Health Issues
Suter, S., & Lucock, M. D. (2017) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2017.00023 · Cited by 8
Grape Polyphenols in the Prevention of Cardiovascular Disease
Gross, M. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-28995-3_3 · Cited by 6
Resveratrol: Is It Really Good for Liver Health?
Weiskirchen, S., & Weiskirchen, R. (2017) · Hepatitis Monthly · doi:10.5812/hepatmon.12074 · Cited by 5
Biomarkers of the metabolic syndrome: influence of selected foodstuffs, containing bioactive components
Robberecht, H. J., Bruyne, T. D., & Hermans, N. (2017) · Phytochemistry Reviews · doi:10.1007/s11101-017-9538-9 · Cited by 6
Resveratrol: A Narrative Review Regarding Its Mechanisms in Mitigating Obesity‐Associated Metabolic Disorders
Cai, Y., & Chen, Q. (2024) · Phytotherapy Research · doi:10.1002/ptr.8416 · Cited by 4
Dietary intake of plant polyphenols: Exploring trend in the Czech population
Sedláček, P., Bludovská, M., Plavinová, I., Zavaďáková, A., Müller, L., & Müllerová, D. (2024) · Central European Journal of Public Health · doi:10.21101/cejph.a7994 · Cited by 3
Blueberries Reduce Palm Oil‐Induced Metabolic Endotoxemia in an In Vitro Human Intestinal‐Immune Cell Model
Casademont‐Roca, A., Tomassen, M. M. M., Kersten, S., Steegenga, W. T., Hooiveld, G. J. E. J., & Mes, J. J. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70311 · Cited by 2
Phytochemicals alter foam cell formation and macrophage cholesterol efflux
Pan, Z., & Ling, W. (2026) · Metabolism and Diseases · doi:10.1016/j.metdis.2026.100003 · Cited by 1
Efeitos do resveratrol nas células cancerígenas
de Souza, G. D. N. B., & Ferreira, J. C. D. S. (2022) · Research Society and Development · doi:10.33448/rsd-v11i6.28841 · Cited by 1
Review of resveratrol for the management of hyperlipidemia and survey
Shelton, A. N., Potts, L. T., & Hailemeskel, B. (2023) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2023.9.1.0338 · Cited by 1
Obesity and Cardiovascular Disease: Impact of Resveratrol as a Therapeutic
Louis, X. L., Krishnan, S. K., Wigle, J. T., & Netticadan, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-47336-5_15 · Cited by 1
20. Resveratrol and metabolic syndrome in obese men – a review
Solverson, P. M., Novotny, J. A., & Castonguay, T. W. (2017) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-853-7_20
Acetylcarnitine
Bruls, Y. M. H. (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180614yb
Pharmacological Treatment for Aging: Are We There?
Barrera-Vázquez, O. S., & Gómez-Verján, J. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_12
Changes in Immunological Parameters in Patients Treated Using Direct and Indirect Restorations of the Hard Tissues of the Anterior Teeth in Combination with an Antioxidant
Kumhyr, I. R. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i3.10708
Lipoproteins in the postprandial state: Studies on the metabolism of triglyceride-rich lipoproteins using multicompartmental models
Björnson, E. (2021) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Comparison between red wine and isolated trans-resveratrol in the prevention and regression of atherosclerosis in LDLr (-/-) mice
Chassot, L. N. (2018) · doi:10.11606/d.9.2018.tde-24052018-135042

Authors: Dash, S., Xiao, C., Morgantini, C., Szeto, L., & Lewis, G. F.
Affiliations: Scuola Superiore Sant'Anna (IT)
Corresponding author: Dash, Satya
Xiao, Changting
ORCID: Dash, Satya
Xiao, Changting
Morgantini, Cecilia
Lewis, Gary F.
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2013-12
Volume: 33
Issue: 12
Pages: 2895-2901
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/atvbaha.113.302342
OpenAlex: W2165712074
Cited by: 102
References: 33
Citations by year: 2026: 3 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 11 · 2017: 12 · 2016: 13 · 2015: 15 · 2014: 10
FWCI: 5.89
Type: journal article
Language: en
Open access: closed
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords: resveratrol, hypertriglyceridemia, apolipoprotein B-100, apolipoprotein B-48, VLDL, chylomicrons, lipoprotein production, lipoprotein turnover, fractional catabolic rate, obesity, insulin resistance, triglyceride-rich lipoproteins
MeSH terms: Resveratrol, Adult, Analysis of Variance, Hypolipidemic Agents, Double-Blind Method, Drug Administration Schedule, Humans, Insulin Resistance, Intestinal Mucosa, Intestines, Lipoproteins, Liver, Male, Middle Aged, Obesity, Ontario, Stilbenes, Time Factors, Triglycerides, Hypertriglyceridemia, Biomarkers, Treatment Outcome, Cross-Over Studies, Overweight, Apolipoprotein B-48, Apolipoprotein B-100

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks